Skip to main content
PMC home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1994 May;112(1):332–340. doi: 10.1111/j.1476-5381.1994.tb13073.x

Effects of phosphodiesterase isoenzyme inhibitors on cutaneous inflammation in the guinea-pig.

M M Teixeira 1, A G Rossi 1, T J Williams 1, P G Hellewell 1
PMCID: PMC1910321  PMID: 8032659

Abstract

1. Inflammation is central to the pathophysiology of asthma. The recent findings that different inflammatory cells may express different phosphodiesterase (PDE) isoenzymes have centered attention on inhibitors of these isoenzymes as new drugs for the treatment of asthma. In this study, we investigated the effect of different PDE isoenzyme inhibitors on the accumulation of 111In-labelled eosinophils and local oedema formation at sites of allergic- and mediator-induced inflammation in guinea-pig skin. 2. Systemic treatment with SK&F 94120, a type III PDE inhibitor, or zaprinast, a type V PDE inhibitor, had no effect on the 111In-eosinophil accumulation and oedema formation induced by i.d. injection of zymosan-activated plasma (ZAP), PAF, histamine or in a passive cutaneous anaphylaxis (PCA) reaction. 3. Systemic treatment with rolipram, a type IV PDE inhibitor, effectively inhibited 111In-eosinophil accumulation induced by ZAP, PAF, histamine and in a PCA reaction. However, oedema formation measured in the same sites was not affected. Systemic administration of higher doses of theophylline produced similar results. In contrast, 111In-neutrophil accumulation induced by ZAP or in a PCA reaction was not altered by systemic treatment with rolipram. 4. Locally-injected rolipram had little effect on 111In-eosinophil accumulation and oedema formation induced by histamine, PAF and in a PCA reaction. 5. These data show that systemic, but not local, treatment with rolipram effectively inhibits allergic- and mediator-induced 111In-eosinophil accumulation but not oedema formation or 111In-neutrophil accumulation.(ABSTRACT TRUNCATED AT 250 WORDS)

Full text

PDF

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Beavo J. A., Reifsnyder D. H. Primary sequence of cyclic nucleotide phosphodiesterase isozymes and the design of selective inhibitors. Trends Pharmacol Sci. 1990 Apr;11(4):150–155. doi: 10.1016/0165-6147(90)90066-H. [DOI] [PubMed] [Google Scholar]
  2. Bentley A. M., Menz G., Storz C., Robinson D. S., Bradley B., Jeffery P. K., Durham S. R., Kay A. B. Identification of T lymphocytes, macrophages, and activated eosinophils in the bronchial mucosa in intrinsic asthma. Relationship to symptoms and bronchial responsiveness. Am Rev Respir Dis. 1992 Aug;146(2):500–506. doi: 10.1164/ajrccm/146.2.500. [DOI] [PubMed] [Google Scholar]
  3. Bruijnzeel-Koomen C., Storz E., Menz G., Bruijnzeel P. Skin eosinophilia in patients with allergic and nonallergic asthma and atopic dermatitis. J Allergy Clin Immunol. 1992 Jan;89(1 Pt 1):52–59. doi: 10.1016/s0091-6749(05)80040-5. [DOI] [PubMed] [Google Scholar]
  4. Dent G., Giembycz M. A., Rabe K. F., Barnes P. J. Inhibition of eosinophil cyclic nucleotide PDE activity and opsonised zymosan-stimulated respiratory burst by 'type IV'-selective PDE inhibitors. Br J Pharmacol. 1991 Jun;103(2):1339–1346. doi: 10.1111/j.1476-5381.1991.tb09790.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Djukanović R., Roche W. R., Wilson J. W., Beasley C. R., Twentyman O. P., Howarth R. H., Holgate S. T. Mucosal inflammation in asthma. Am Rev Respir Dis. 1990 Aug;142(2):434–457. doi: 10.1164/ajrccm/142.2.434. [DOI] [PubMed] [Google Scholar]
  6. Faccioli L. H., Nourshargh S., Moqbel R., Williams F. M., Sehmi R., Kay A. B., Williams T. J. The accumulation of 111In-eosinophils induced by inflammatory mediators, in vivo. Immunology. 1991 Jun;73(2):222–227. [PMC free article] [PubMed] [Google Scholar]
  7. Foster C. S., Rice B. A., Dutt J. E. Immunopathology of atopic keratoconjunctivitis. Ophthalmology. 1991 Aug;98(8):1190–1196. doi: 10.1016/s0161-6420(91)32154-7. [DOI] [PubMed] [Google Scholar]
  8. Giembycz M. A., Dent G. Prospects for selective cyclic nucleotide phosphodiesterase inhibitors in the treatment of bronchial asthma. Clin Exp Allergy. 1992 Mar;22(3):337–344. doi: 10.1111/j.1365-2222.1992.tb03095.x. [DOI] [PubMed] [Google Scholar]
  9. Gristwood R. W., Llupiá J., Fernández A. G., Berga P. Effects of theophylline compared with prednisolone on late phase airway leukocyte infiltration in guinea pigs. Int Arch Allergy Appl Immunol. 1991;94(1-4):293–294. doi: 10.1159/000235388. [DOI] [PubMed] [Google Scholar]
  10. Griswold D. E., Webb E. F., Breton J., White J. R., Marshall P. J., Torphy T. J. Effect of selective phosphodiesterase type IV inhibitor, rolipram, on fluid and cellular phases of inflammatory response. Inflammation. 1993 Jun;17(3):333–344. doi: 10.1007/BF00918994. [DOI] [PubMed] [Google Scholar]
  11. Gundel R. H., Letts L. G., Gleich G. J. Human eosinophil major basic protein induces airway constriction and airway hyperresponsiveness in primates. J Clin Invest. 1991 Apr;87(4):1470–1473. doi: 10.1172/JCI115155. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Howell R. E., Sickels B. D., Woeppel S. L. Pulmonary antiallergic and bronchodilator effects of isozyme-selective phosphodiesterase inhibitors in guinea pigs. J Pharmacol Exp Ther. 1993 Feb;264(2):609–615. [PubMed] [Google Scholar]
  13. Johnston I. D. Theophylline in the management of airflow obstruction. 2. Difficult drugs to use, few clinical indications. BMJ. 1990 Apr 7;300(6729):929–931. doi: 10.1136/bmj.300.6729.929. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Klementsson H. Eosinophils and the pathophysiology of allergic rhinitis. Clin Exp Allergy. 1992 Dec;22(12):1058–1064. doi: 10.1111/j.1365-2222.1992.tb00130.x. [DOI] [PubMed] [Google Scholar]
  15. Kuehl F. A., Jr, Zanetti M. E., Soderman D. D., Miller D. K., Ham E. A. Cyclic AMP-dependent regulation of lipid mediators in white cells. A unifying concept for explaining the efficacy of theophylline in asthma. Am Rev Respir Dis. 1987 Jul;136(1):210–213. doi: 10.1164/ajrccm/136.1.210. [DOI] [PubMed] [Google Scholar]
  16. Montefort S., Herbert C. A., Robinson C., Holgate S. T. The bronchial epithelium as a target for inflammatory attack in asthma. Clin Exp Allergy. 1992 May;22(5):511–520. doi: 10.1111/j.1365-2222.1992.tb00159.x. [DOI] [PubMed] [Google Scholar]
  17. Morley J. Immunopharmacology of asthma. Immunol Today. 1993 Jun;14(6):317–322. doi: 10.1016/0167-5699(93)90052-M. [DOI] [PubMed] [Google Scholar]
  18. Nassif E. G., Weinberger M., Thompson R., Huntley W. The value of maintenance theophylline in steroid-dependent asthma. N Engl J Med. 1981 Jan 8;304(2):71–75. doi: 10.1056/NEJM198101083040202. [DOI] [PubMed] [Google Scholar]
  19. Newsholme S. J., Schwartz L. cAMP-specific phosphodiesterase inhibitor, rolipram, reduces eosinophil infiltration evoked by leukotrienes or by histamine in guinea pig conjunctiva. Inflammation. 1993 Feb;17(1):25–31. doi: 10.1007/BF00916389. [DOI] [PubMed] [Google Scholar]
  20. Nicholson C. D., Challiss R. A., Shahid M. Differential modulation of tissue function and therapeutic potential of selective inhibitors of cyclic nucleotide phosphodiesterase isoenzymes. Trends Pharmacol Sci. 1991 Jan;12(1):19–27. doi: 10.1016/0165-6147(91)90484-a. [DOI] [PubMed] [Google Scholar]
  21. Nielson C. P., Crowley J. J., Morgan M. E., Vestal R. E. Polymorphonuclear leukocyte inhibition by therapeutic concentrations of theophylline is mediated by cyclic-3',5'-adenosine monophosphate. Am Rev Respir Dis. 1988 Jan;137(1):25–30. doi: 10.1164/ajrccm/137.1.25. [DOI] [PubMed] [Google Scholar]
  22. Nielson C. P., Vestal R. E., Sturm R. J., Heaslip R. Effects of selective phosphodiesterase inhibitors on the polymorphonuclear leukocyte respiratory burst. J Allergy Clin Immunol. 1990 Nov;86(5):801–808. doi: 10.1016/s0091-6749(05)80186-1. [DOI] [PubMed] [Google Scholar]
  23. Ortiz J. L., Cortijo J., Vallés J. M., Morcillo E. J. Rolipram inhibits PAF-induced airway microvascular leakage in guinea-pig: a comparison with milrinone and theophylline. Fundam Clin Pharmacol. 1992;6(6):247–249. doi: 10.1111/j.1472-8206.1992.tb00117.x. [DOI] [PubMed] [Google Scholar]
  24. Persson C. G. Overview of effects of theophylline. J Allergy Clin Immunol. 1986 Oct;78(4 Pt 2):780–787. doi: 10.1016/0091-6749(86)90061-8. [DOI] [PubMed] [Google Scholar]
  25. Pober J. S., Slowik M. R., De Luca L. G., Ritchie A. J. Elevated cyclic AMP inhibits endothelial cell synthesis and expression of TNF-induced endothelial leukocyte adhesion molecule-1, and vascular cell adhesion molecule-1, but not intercellular adhesion molecule-1. J Immunol. 1993 Jun 1;150(11):5114–5123. [PubMed] [Google Scholar]
  26. Schudt C., Winder S., Forderkunz S., Hatzelmann A., Ullrich V. Influence of selective phosphodiesterase inhibitors on human neutrophil functions and levels of cAMP and Cai. Naunyn Schmiedebergs Arch Pharmacol. 1991 Dec;344(6):682–690. doi: 10.1007/BF00174752. [DOI] [PubMed] [Google Scholar]
  27. Souness J. E., Carter C. M., Diocee B. K., Hassall G. A., Wood L. J., Turner N. C. Characterization of guinea-pig eosinophil phosphodiesterase activity. Assessment of its involvement in regulating superoxide generation. Biochem Pharmacol. 1991 Jul 25;42(4):937–945. doi: 10.1016/0006-2952(91)90056-b. [DOI] [PubMed] [Google Scholar]
  28. Spicer B. A., Baker R. C., Hatt P. A., Laycock S. M., Smith H. The effects of drugs on Sephadex-induced eosinophilia and lung hyper-responsiveness in the rat. Br J Pharmacol. 1990 Dec;101(4):821–828. doi: 10.1111/j.1476-5381.1990.tb14164.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Suttorp N., Weber U., Welsch T., Schudt C. Role of phosphodiesterases in the regulation of endothelial permeability in vitro. J Clin Invest. 1993 Apr;91(4):1421–1428. doi: 10.1172/JCI116346. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Teixeira M. M., Reynia S., Robinson M., Shock A., Williams T. J., Williams F. M., Rossi A. G., Hellewell P. G. Role of CD18 in the accumulation of eosinophils and neutrophils and local oedema formation in inflammatory reactions in guinea-pig skin. Br J Pharmacol. 1994 Mar;111(3):811–818. doi: 10.1111/j.1476-5381.1994.tb14810.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Teixeira M. M., Williams T. J., Hellewell P. G. E-type prostaglandins enhance local oedema formation and neutrophil accumulation but suppress eosinophil accumulation in guinea-pig skin. Br J Pharmacol. 1993 Sep;110(1):416–422. doi: 10.1111/j.1476-5381.1993.tb13826.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Teixeira M. M., Williams T. J., Hellewell P. G. Role of prostaglandins and nitric oxide in acute inflammatory reactions in guinea-pig skin. Br J Pharmacol. 1993 Dec;110(4):1515–1521. doi: 10.1111/j.1476-5381.1993.tb13994.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Torphy T. J., Undem B. J., Cieslinski L. B., Luttmann M. A., Reeves M. L., Hay D. W. Identification, characterization and functional role of phosphodiesterase isozymes in human airway smooth muscle. J Pharmacol Exp Ther. 1993 Jun;265(3):1213–1223. [PubMed] [Google Scholar]
  34. Torphy T. J., Undem B. J. Phosphodiesterase inhibitors: new opportunities for the treatment of asthma. Thorax. 1991 Jul;46(7):512–523. doi: 10.1136/thx.46.7.512. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Townley R. G. Elevated cAMP-phosphodiesterase in atopic disease: cause or effect? J Lab Clin Med. 1993 Jan;121(1):15–17. [PubMed] [Google Scholar]
  36. Underwood D. C., Osborn R. R., Novak L. B., Matthews J. K., Newsholme S. J., Undem B. J., Hand J. M., Torphy T. J. Inhibition of antigen-induced bronchoconstriction and eosinophil infiltration in the guinea pig by the cyclic AMP-specific phosphodiesterase inhibitor, rolipram. J Pharmacol Exp Ther. 1993 Jul;266(1):306–313. [PubMed] [Google Scholar]
  37. Venge P. The human eosinophil in inflammation. Agents Actions. 1990 Jan;29(1-2):122–126. doi: 10.1007/BF01964739. [DOI] [PubMed] [Google Scholar]
  38. Ward A. J., McKenniff M., Evans J. M., Page C. P., Costello J. F. Theophylline--an immunomodulatory role in asthma? Am Rev Respir Dis. 1993 Mar;147(3):518–523. doi: 10.1164/ajrccm/147.3.518. [DOI] [PubMed] [Google Scholar]
  39. Wardlaw A. J., Dunnette S., Gleich G. J., Collins J. V., Kay A. B. Eosinophils and mast cells in bronchoalveolar lavage in subjects with mild asthma. Relationship to bronchial hyperreactivity. Am Rev Respir Dis. 1988 Jan;137(1):62–69. doi: 10.1164/ajrccm/137.1.62. [DOI] [PubMed] [Google Scholar]
  40. Weg V. B., Watson M. L., Cordeiro R. S., Williams T. J. Histamine, leukotriene D4 and platelet-activating factor in guinea pig passive cutaneous anaphylaxis. Eur J Pharmacol. 1991 Nov 5;204(2):157–163. doi: 10.1016/0014-2999(91)90700-z. [DOI] [PubMed] [Google Scholar]
  41. Weg V. B., Williams T. J., Lobb R. R., Nourshargh S. A monoclonal antibody recognizing very late activation antigen-4 inhibits eosinophil accumulation in vivo. J Exp Med. 1993 Feb 1;177(2):561–566. doi: 10.1084/jem.177.2.561. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. de Boer J., Philpott A. J., van Amsterdam R. G., Shahid M., Zaagsma J., Nicholson C. D. Human bronchial cyclic nucleotide phosphodiesterase isoenzymes: biochemical and pharmacological analysis using selective inhibitors. Br J Pharmacol. 1992 Aug;106(4):1028–1034. doi: 10.1111/j.1476-5381.1992.tb14451.x. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES